CN Patent

CN118121699A — Tpk激动剂及使用其治疗神经退行性疾病的方法

Assigned to Shanghai Rixin Pharmaceutical Technology Co ltd · Expires 2024-06-04 · 2y expired

What this patent protects

TPK激动剂及使用其治疗神经退行性疾病的方法。本公开属于生物医药领域，并具体涉及预防或治疗神经退行性疾病或者减轻神经退行性疾病的症状的方法，其包括向需要其的个体给药预防或治疗有效量的硫胺素焦磷酸激酶(TPK)激动剂。

USPTO Abstract

TPK激动剂及使用其治疗神经退行性疾病的方法。本公开属于生物医药领域，并具体涉及预防或治疗神经退行性疾病或者减轻神经退行性疾病的症状的方法，其包括向需要其的个体给药预防或治疗有效量的硫胺素焦磷酸激酶(TPK)激动剂。

Drugs covered by this patent

Patent Metadata

Patent number
CN118121699A
Jurisdiction
CN
Classification
—
Expires
2024-06-04
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Rixin Pharmaceutical Technology Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.